188914-67-2 Usage
Molecular structure
The compound has a pyrroloimidazolidine core and a tetrahydro-2-[[4-(2-methoxyphenyl)-1-piperazinyl]methyl]substituent.
Heterocyclic ring system
The compound contains a heterocyclic ring system, which is a ring structure containing both carbon and non-carbon atoms such as nitrogen or oxygen.
Piperazine group
The compound has a piperazine group, which is a chemical structure composed of two five-membered rings (pyrroles) fused together.
Methoxyphenyl substitution
The compound has a methoxyphenyl group attached to the piperazine group, which is a phenyl ring with a methoxy substituent.
Pharmaceutical and medicinal applications
The compound has potential pharmaceutical and medicinal applications due to its possible biological activity and its use as a starting material for the synthesis of various drug candidates.
Importance in medicinal chemistry and drug discovery
The compound's precise structure makes it an important target for research and development in the field of medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 188914-67-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,9,1 and 4 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 188914-67:
(8*1)+(7*8)+(6*8)+(5*9)+(4*1)+(3*4)+(2*6)+(1*7)=192
192 % 10 = 2
So 188914-67-2 is a valid CAS Registry Number.
188914-67-2Relevant academic research and scientific papers
Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1,3- dioxoperhydroimidazo[1,5-a]pyridine: A selective 5-HT(1A) receptor agonist
López-Rodríguez, María L.,Rosado, Ma. Luisa,Benhamú, Bellinda,Morcillo, Ma. José,Sanz, Antonio M.,Orensanz, Luis,Beneitez, Ma. Eugenia,Fuentes, José A.,Manzanares, Jorge
, p. 4439 - 4450 (2007/10/03)
A series of new bicyclohydantoin-arylpiperazines was prepared and evaluated for affinity at 5-HT(1A), α1, and D2 receptors. Most of the compounds showed very low affinity for D2 receptors, and most of them demonstrated mod
